'Am j kidney dis' diaporamas de présentation

Treatment of catheter-related infections

1.79k views • 97 slides

Hypertension in pregnancy

Hypertension in pregnancy. Classification. Gestational hypertension:>=140/90,>20 wks,no proteinuria,resolves PP Preeclampsia: above + proteinuria >=+1 Eclampsia : preeclampsia + convulsions Chronic HT : < 20 wks,ct > 12 wks PP, +/- proteinuria

1.62k views • 97 slides

Anti-coagulants during Hemodialysis

Bancha Satirapoj , MD Division of Nephrology Department of Medicine Phramongkutklao Hospital and College of Medicine. Anti-coagulants during Hemodialysis. Dialysis and Thrombosis. Kidney disease Inflammation E ndothelial injury Expression and activity of procoagulant factors

1.26k views • 71 slides

Heart and Kidney: Protect Your Kidneys to Save Your Heart

798 views • 59 slides

Hypertension: A Tale of Two Worlds

Hypertension: A Tale of Two Worlds. Christina Lankhorst, MD FNKF September 14, 2012. Disclosures. Sanford Nephrology On NKF education committee No financial disclosures. Objectives. Define outpatient hypertension. Discuss recommendations for control.

489 views • 48 slides

RENAL REPLACEMENT THERAPY IN PATIENTS WITH SEPSIS AND ACUTE KIDNEY INJURY

RENAL REPLACEMENT THERAPY IN PATIENTS WITH SEPSIS AND ACUTE KIDNEY INJURY. Prof. Dr. Raymond Vanholder University Hospital Ghent Belgium . TIMING START RRT. ES: Early Start; BUN: Blood Urea Nitrogen ; UO: urine output; + favors ES; 0 neutral

820 views • 39 slides

Acute Renal Failure and Sepsis

Acute Renal Failure and Sepsis. Volume 351:159-169 July 8, 2004 Number 2 Robert W. Schrier, M.D., and Wei Wang, M.D. R/ ???. Acute Renal Failure and Sepsis.

605 views • 39 slides

ACE / ARB: renovascular hypertension and nephroprotection

ACE / ARB: renovascular hypertension and nephroprotection. Johan Rosman Renal Physician and CMO Specialist in Hypertension Waitemata DHB, and Apollo Centre , Albany info@bloodpressure.org.nz. Omapere , October 09. A fascinating animal for BP research. Why does a giraffe not faint ?

684 views • 39 slides

Prevention of Contrast-Induced Nephropathy (CIN) Sepehr Khashaei , MD Assistant professor Department of Internal Medicin

Prevention of Contrast-Induced Nephropathy (CIN) Sepehr Khashaei , MD Assistant professor Department of Internal Medicine. What will be covered today?. Definition of CIN Why is prevention of CIN important? Some other information/statistics about CIN Who is at high risk for CIN?

539 views • 37 slides

Assessment of the New AVF for Maturity

1.62k views • 35 slides

Assessment of the New AVF for Maturity

775 views • 35 slides

AMPHOTERICIN B NEPHROTOXICITY

AMPHOTERICIN B NEPHROTOXICITY . GILBERT DERAY PARIS , FRANCE. * Amphotericin B (AmB) remains the most effective drug in treating systemic fungal infections. * Amphotericin B can produce a wide variety of acute and chronic side effects, the most important of which is nephrotoxicity .

1.22k views • 34 slides

Clarissa J. Diamantidis, MD, MHS October 2013

Educating Chronic Kidney Disease Patients Through Health Information Technology: Can They Hear You Now?. Clarissa J. Diamantidis, MD, MHS October 2013. Chronic Kidney Disease (CKD). Coresh J, et al. JAMA. 2007. . CKD Care Barriers. Low patient awareness Limited health literacy

398 views • 29 slides

Advanced care Planning

446 views • 28 slides

Volume Assessment

Volume Assessment. 2010. Old Paradigm. Na + = Volume H 2 O = Tonicity. ICF. ECF. Blood. TBW. Left sided failure DOE Orthopnea 90% sensitivity corr c pcwp PND. Right-sided Failure Abdominal pain Early satiety Nausea/vomiting Non-specific Fatigue Feeling cold Altered mentation.

298 views • 25 slides

Assesment of renal function in case of near normal creatinine (<1.5 )

Assesment of renal function in case of near normal creatinine (<1.5 ). Naseer Khan MD . Burden of CKD Stage II in USA. According to the NHANES III-study the prevalence of stage 2 chronic kidney disease is 3% in the American population i.e. about 9000000 persons are afflicted.

468 views • 25 slides

Number of patients worldwide treated with chronic dialysis from 1990 to 2010

Number of patients worldwide treated with chronic dialysis from 1990 to 2010. 2,500,000. 1,490,000. 426,000. 1990. 2010. 2000. Lysaght, J Am Soc Nephrol, 2002. $. $. $. $. $. $. Predicted costs for chronic dialysis worldwide per decade from 1980 until 2010 . 1200. 1000. 800.

289 views • 18 slides

21, July 2010

Antiretroviral Regimen and Pharmacogenetic Determinants of Tenofovir-associated Change in Creatinine Clearance in ACTG Protocol A5142 (NWCS 291). Miguel Goicoechea, Yu Zheng, Michael Hughes, Sharon Riddler, Michael Neely, David Haas, Stan Louie and Richard Haubrich. 21, July 2010. Background.

276 views • 17 slides

QUALITY USE OF CARDIOVASCULAR MEDICATION

326 views • 14 slides

Overview: Pre-renal Disease and Acute Tubular Necrosis

Overview: Pre-renal Disease and Acute Tubular Necrosis. By: David I. Driver, MS III. Introduction.

230 views • 7 slides